Sleep duration and lipid metabolism in patients with diabetes mellitus: from the POWER2DM study.

Diabetes mellitus High-density lipoprotein cholesterol Lipid metabolism Sleep duration

Journal

Sleep and biological rhythms
ISSN: 1446-9235
Titre abrégé: Sleep Biol Rhythms
Pays: Japan
ID NLM: 101199488

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 07 02 2022
accepted: 04 07 2022
medline: 5 8 2022
pubmed: 5 8 2022
entrez: 12 3 2024
Statut: epublish

Résumé

This study assesses the association between sleep duration and plasma lipid profiles in people with diabetes mellitus (DM). Sleep duration data were obtained in 91 patients from the POWER2DM study (NCT03588104). The patients were divided in tertiles, based on their sleep duration, and blood samples were obtained at the beginning and after 9 months. Significant differences were found, specifically, patients in Tertile 3 (≥ 7.51 h) showed lower plasma levels of high-density lipoprotein cholesterol HDL-c (

Identifiants

pubmed: 38468620
doi: 10.1007/s41105-022-00403-7
pii: 403
pmc: PMC10899896
doi:

Types de publication

Journal Article

Langues

eng

Pagination

595-599

Informations de copyright

© The Author(s), under exclusive licence to Japanese Society of Sleep Research 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Déclaration de conflit d'intérêts

Conflict of interestIsabel Perez-Corral, Francisco Gomez-Delgado, Merel M Ruissen, Jose D Torres-Peña, Antonio P Arenas-de Larriva, Jacob K Sont, Albert A de Graaf, Bas S Uitbeijerse, Eelco J P de Koning and Javier Delgado-Lista declare that they have no conflict of interest.

Auteurs

Isabel Perez-Corral (I)

Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Avda. Menendez Pidal, S/N., 14004 Cordoba, Spain.
Department of Medical and Surgical Sciences, University of Cordoba, 14004 Cordoba, Spain.
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
CIBER Fisiopatologia de La Obesidad Y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Francisco Gomez-Delgado (F)

Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Avda. Menendez Pidal, S/N., 14004 Cordoba, Spain.
Department of Medical and Surgical Sciences, University of Cordoba, 14004 Cordoba, Spain.
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
CIBER Fisiopatologia de La Obesidad Y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Merel M Ruissen (MM)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Zuid-Holland The Netherlands.

Jose D Torres-Peña (JD)

Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Avda. Menendez Pidal, S/N., 14004 Cordoba, Spain.
Department of Medical and Surgical Sciences, University of Cordoba, 14004 Cordoba, Spain.
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
CIBER Fisiopatologia de La Obesidad Y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Antonio P Arenas-de Larriva (APA)

Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Avda. Menendez Pidal, S/N., 14004 Cordoba, Spain.
Department of Medical and Surgical Sciences, University of Cordoba, 14004 Cordoba, Spain.
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
CIBER Fisiopatologia de La Obesidad Y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Jacob K Sont (JK)

Department of Biomedical Data Sciences, Section Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.

Albert A de Graaf (AA)

Department Risk Analysis for Products in Development, The Netherlands Organization for Applied Scientific Research (TNO), 3508 TA Utrecht, The Netherlands.

Bas S Uitbeijerse (BS)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Zuid-Holland The Netherlands.

Eelco J P de Koning (EJP)

Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Zuid-Holland The Netherlands.

Javier Delgado-Lista (J)

Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Avda. Menendez Pidal, S/N., 14004 Cordoba, Spain.
Department of Medical and Surgical Sciences, University of Cordoba, 14004 Cordoba, Spain.
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
CIBER Fisiopatologia de La Obesidad Y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Classifications MeSH